Cimatron Reports Record Revenues

For those unable to listen to the live call, a replay of the call will be available from the day after the call under the investor relations section of Cimatron's website, at: http://www.cimatron.com

About Cimatron

With over 25 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM solutions for mold, tool and die makers as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles, enable collaboration with outside vendors, and ultimately shorten product delivery time.

The Cimatron product line includes the CimatronE and GibbsCAM brands with solutions for mold design, die design, electrodes design, 2.5 to 5 axes milling, wire EDM, turn, Mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron's subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.

Cimatron is publicly traded on the NASDAQ exchange under the symbol CIMT. For more information, please visit the company web site at: http://www.cimatron.com.

Safe Harbor Statement

This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act Of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to the company's plans, objectives and expected financial and operating results. The words "may," "could," "would," "will," "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of the future performance and involve risks and uncertainties, many of which are beyond the company's ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycle, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties of the business, refer to the Company's filings with the Securities and Exchanges Commission. The company cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.

                                 CIMATRON LIMITED
                         CONSOLIDATED STATEMENTS OF INCOME
               (US Dollars in thousands, except for per share data)

                                   June 30,                   June 30,
                             2008          2007          2008           2007

    Total revenue          10,701         5,511        20,707         10,844

    Total cost of revenue   1,922           806         3,916          1,677

    Gross profit            8,779         4,705        16,791          9,167

    Research and
    development
    expenses, net           1,833         1,011         3,590          2,107

    Selling, general and
    administrative expenses 6,873         3,412        13,346          6,665
    Operating (loss) income    73           282          (145)           395

    Financial Income, net.     80            76            35            145

    Taxes on Income            48            (2)            7             (4)

    Other                       4           (65)           10            (64)

    Net income (loss)       $ 205         $ 291         $ (93)         $ 472
    Net income (loss) per
    share - basic and
    diluted       $ 0.02   $ 0.04       $ (0.01)       $ 0.06

    Weighted average number
    of shares outstanding

    Basic EPS (in
    thousands)              9,386         7,868         9,371          7,852

    Diluted EPS (in
    thousands)              9,441         7,967         9,425          7,871



                                CIMATRON LIMITED
              RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION
              (US Dollars in thousands, except for per share data)

                                         Three months ended
                                               June 30,
                                  2008                                    2007
                                                  GAAP          Adj.      NON-GAAP        GAAP        Adj.      NON-GAAP

        Total  revenue  (1)    10,701            248          10,949      5,511              -            5,511

        Total  cost  of
        revenue  (2)                  1,922          (147)          1,775          806              -                806

        Gross  profit                8,779            395            9,174      4,705              -            4,705

        Research  and
        development
        expenses,  net              1,833                -            1,833      1,011              -            1,011

        Selling,  general
        and  administrative
        expenses  (2)                6,873          (100)          6,773      3,412          (10)          3,402
        Operating  income
      (loss)                                    73            495                568          282            10                292

        Financial  Income,
        net.                                      80                -                  80            76              -                  76

        Taxes  on  Income  (3)        48              40                  88            (2)            -                  (2)

        Other                                      4                -                    4          (65)            -                (65)

        Net  income  (loss)      $  205        $  535            $  740      $  291        $  10            $  301
        Net  income  (loss)
        per  share  -  basic
        and  diluted                $  0.02                            $  0.08    $  0.04                          $  0.04
        Weighted  average
        number  of  shares
        outstanding

        Basic  EPS  (in
        thousands)                    9,386                              9,386      7,868                            7,868

        Diluted  EPS  (in
        thousands)                    9,441                              9,441      7,967                            7,967

        (1)  Non-GAAP  adjustment  related  to  Gibbs'  assumed  support  contracts  that
                will  not  be  recognized  on  a  GAAP  basis  in  fiscal  2008  or  thereafter
                due  to  business  combination  accounting  rules.
        (2)  Non-GAAP  adjustment  to  exclude  non-cash  amortization  of  acquired
                intangible  assets.
        (3)  Non-GAAP  adjustment  to  exclude  deferred  taxes  related  to  business
                combination  accounting  rules.



                                                                CIMATRON  LIMITED
                    RECONCILIATION  BETWEEN  GAAP  AND  NON-GAAP  INFORMATION  (Cont.)
                            (US  Dollars  in  thousands,  except  for  per  share  data)


                                                                                    Six  months  ended
                                                                                              June  30,
                                                                    2008                                            2007
                                                  GAAP          Adj.    NON-GAAP          GAAP      Adj.        NON-GAAP

        Total  revenue  (1)    20,707            495        21,202      10,844                          10,844

        Total  cost  of
        revenue  (2)                  3,916          (294)        3,622        1,677                            1,677

        Gross  profit              16,791            789        17,580        9,167                            9,167

        Research  and
        development
        expenses,  net              3,590                            3,590        2,107                            2,107
        Selling,  general
        and  administrative
        expenses  (2)              13,346          (200)      13,146        6,665        (20)            6,645
        Operating  income
        (loss)                              (145)          989              844            395          20                  415

        Financial  Income,
        net.                                      35                                  35            145                                145

        Taxes  on  Income
        (3)                                          7              78                85              (4)                                (4)

        Other                                    10                                  10            (64)                              (64)

        Net  income  (loss)      $  (93)  $  1,067              974            472      $  20                  492
        Net  income  (loss)
        per  share  -  basic
        and  diluted              $  (0.01)                        $  0.10      $  0.06                          $  0.06
        Weighted  average
        number  of  shares
        outstanding

        Basic  EPS  (in
        thousands)                    9,371                            9,371        7,852                            7,852

        Diluted  EPS  (in
        thousands)                    9,425                            9,425        7,871                            7,871

        (1)  Non-GAAP  adjustment  related  to  Gibbs'  assumed  support  contracts  that
                will  not  be  recognized  on  a  GAAP  basis  in  fiscal  2008  or  thereafter
                due  to  business  combination  accounting  rules.
        (2)  Non-GAAP  adjustment  to  exclude  non-cash  amortization  of  acquired
                intangible  assets.
        (3)  Non-GAAP  adjustment  to  exclude  deferred  taxes  related  to  business
                combination  accounting  rules.



                                                                        CIMATRON  LIMITED
                                                            CONSOLIDATED  BALANCE  SHEETS
                                                                (US  Dollars  in  thousands)

                                                                                                June  30,              December  31,
                                                                                                    2008                          2007

        ASSETS
        CURRENT  ASSETS:
        Total  cash,  cash  equivalents  and
        short-term  investments                                              $  9,169                        $  9,026
        Trade  receivables                                                            7,740                            7,308
        Other  current  assets                                                      2,835                            1,467
        Total  current  assets                                                    19,744                          17,801

        Deposits  with  insurance  companies  and
        severance  pay  fund                                                          3,298                            2,703

        LONG-TERM  INVESTMENTS:
        Marketable  investments                                                          -                            1,158

        Net  property  and  equipment                                          1,556                            1,337

        Total  other  assets                                                        14,412                            4,328

        Total  assets                                                                $  39,010                      $  27,327

        LIABILITIES  AND  SHAREHOLDERS'  EQUITY
        CURRENT  LIABILITIES:
        Short-term  bank  credit                                                  $  129                            $  791
        Trade  payables                                                                  2,197                            2,258
        Accrued  expenses  and  other  liabilities                  9,056                            7,889
        Deferred  revenues                                                            5,171                                742
        Total  current  liabilities                                          16,553                          11,680

        LONG-TERM  LIABILITIES:
        Accrued  severance  pay                                                    4,597                            3,929
        Long-term  loan                                                                      390                                403
        Other                                                                                    1,910                                282
        Total  long-term  liabilities                                        6,897                            4,614
        Minority  interest                                                                  51                                  63

        Total  shareholders'  equity                                        15,509                          10,970
        Total  liabilities  and  shareholders'
        equity                                                                            $  39,010                      $  27,327



        Contact:
        Ilan  Erez,  Chief  Financial  Officer            Yael  Nevat,
        Cimatron  Ltd.                                                      Commitment-IR.com
        Tel.:  +972-3-531-2121                                      Tel:  +972-9-741  8866
        E-mail:  ilane@cimatron.com                            E-mail:  yael@commitment-IR.com

 


« Previous Page 1 | 2             



© 2024 Internet Business Systems, Inc.
670 Aberdeen Way, Milpitas, CA 95035
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise